Avance Clinical as signed a Memorandum of Understanding (MOU) with Taipei Medical University (TMU), one of Taiwan’s leading medical institutions with extensive clinical trial expertise.
Avance Clinical has further strengthened its presence in Asia with the opening of an office in Taipei, Taiwan.
Avance Clinical is pleased to announce the signing of four Memorandums of Understanding (MOUs) with key clinical trial sites in Taiwan this week.
The success of a biotech drug development program often depends on the relationship it forms with its Clinical Research Organization (CRO) partner.
Simbec-Orion and Avance Clinical are thrilled to announce the signing of a Memorandum of Understanding (MOU), marking a significant milestone in their strategic partnership.
Avance Clinical is pleased to announce its participation in the World Orphan Drug Congress USA, taking place in Boston on April 23-24, 2025.
Avance Clinical excited to announce its participation in BIO-Europe Spring 2025, taking place from March 17–19 in Milan, Italy.
For early-stage biotech companies, securing funding is often a significant challenge due to the complex and costly nature of drug development.
Avance Clinical, with over 30 years of experience as a leading full-service Contract Research Organization (CRO), is looking forward to once again meet with biotechs at Biotech Showcase 2025.
For early-stage biotech companies, securing funding is often a significant challenge due to the complex and costly nature of drug development.
Avance Clinical is a full-service Contract Research Organization (CRO) with clinical operations in Australia, New Zealand, Asia, North America, and Europe.
Level 22, 91 King William Street
Adelaide, SA
Australia 5000
Phone: +61 8 8249 4788
For all media enquiries: media@avancecro.com